Supplementary Figure S1 from TAPISTRY: A Phase II Study of Atezolizumab in Patients with Tumor Mutational Burden–High Tumors
Abstract
Supplementary figure S1 - TAPISTRY overall study design
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Lung Cancer Treatments and Mutations
Cancer Genomics and Diagnostics
Publication details
- Publication date
- 16 March 2026
- Language
- EN